188 related articles for article (PubMed ID: 35202643)
1. Deep Learning-Based Classification of Hepatocellular Nodular Lesions on Whole-Slide Histopathologic Images.
Cheng N; Ren Y; Zhou J; Zhang Y; Wang D; Zhang X; Chen B; Liu F; Lv J; Cao Q; Chen S; Du H; Hui D; Weng Z; Liang Q; Su B; Tang L; Han L; Chen J; Shao C
Gastroenterology; 2022 Jun; 162(7):1948-1961.e7. PubMed ID: 35202643
[TBL] [Abstract][Full Text] [Related]
2. Deep learning-based accurate diagnosis and quantitative evaluation of microvascular invasion in hepatocellular carcinoma on whole-slide histopathology images.
Zhang X; Yu X; Liang W; Zhang Z; Zhang S; Xu L; Zhang H; Feng Z; Song M; Zhang J; Feng S
Cancer Med; 2024 Mar; 13(5):e7104. PubMed ID: 38488408
[TBL] [Abstract][Full Text] [Related]
3. Deep Learning for Approaching Hepatocellular Carcinoma Ultrasound Screening Dilemma: Identification of α-Fetoprotein-Negative Hepatocellular Carcinoma From Focal Liver Lesion Found in High-Risk Patients.
Zhang WB; Hou SZ; Chen YL; Mao F; Dong Y; Chen JG; Wang WP
Front Oncol; 2022; 12():862297. PubMed ID: 35720017
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of focal liver lesions with deep learning-based multi-channel analysis of hepatocyte-specific contrast-enhanced magnetic resonance imaging.
Stollmayer R; Budai BK; Tóth A; Kalina I; Hartmann E; Szoldán P; Bérczi V; Maurovich-Horvat P; Kaposi PN
World J Gastroenterol; 2021 Sep; 27(35):5978-5988. PubMed ID: 34629814
[TBL] [Abstract][Full Text] [Related]
5. Immunostaining of glutamine synthetase is a sensitive and specific marker for diagnosing focal nodular hyperplasia in needle biopsy.
Tsai JH; Jeng YM; Pan CC; Lu SW; Kuo YJ
Pathology; 2012 Dec; 44(7):605-10. PubMed ID: 22990279
[TBL] [Abstract][Full Text] [Related]
6. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T
Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081
[TBL] [Abstract][Full Text] [Related]
7. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.
Wang HL; Anatelli F; Zhai QJ; Adley B; Chuang ST; Yang XJ
Arch Pathol Lab Med; 2008 Nov; 132(11):1723-8. PubMed ID: 18976006
[TBL] [Abstract][Full Text] [Related]
8. SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.
Jin GZ; Yu WL; Dong H; Zhou WP; Gu YJ; Yu H; Yu H; Lu XY; Xian ZH; Liu YK; Cong WM; Wu MC
J Hepatol; 2013 Sep; 59(3):510-7. PubMed ID: 23665285
[TBL] [Abstract][Full Text] [Related]
9. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
Sannier A; Cazejust J; Lequoy M; Cervera P; Scatton O; Rosmorduc O; Wendum D
Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
[TBL] [Abstract][Full Text] [Related]
10. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ
J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063
[TBL] [Abstract][Full Text] [Related]
11. The cytological characteristics of small cell change of dysplasia in small hepatic nodules.
Chang O; Yano Y; Masuzawa A; Fukushima N; Teramura K; Hayashi Y
Oncol Rep; 2010 May; 23(5):1229-32. PubMed ID: 20372834
[TBL] [Abstract][Full Text] [Related]
12. Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma.
Roncalli M; Sciarra A; Tommaso LD
Clin Mol Hepatol; 2016 Jun; 22(2):199-211. PubMed ID: 27189732
[TBL] [Abstract][Full Text] [Related]
13. [Macronodules, dysplastic nodules and cirrhosis].
Cochand-Priollet B; Fabre M
J Radiol; 2001 Mar; 82(3 Pt 1):215-9. PubMed ID: 11287851
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens.
Choi WT; Ramachandran R; Kakar S
Hum Pathol; 2017 May; 63():1-13. PubMed ID: 28087475
[TBL] [Abstract][Full Text] [Related]
15. Grading of hepatocellular carcinoma based on diffusion weighted images with multiple b-values using convolutional neural networks.
Zhou W; Wang G; Xie G; Zhang L
Med Phys; 2019 Sep; 46(9):3951-3960. PubMed ID: 31169907
[TBL] [Abstract][Full Text] [Related]
16. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.
Mokrane FZ; Lu L; Vavasseur A; Otal P; Peron JM; Luk L; Yang H; Ammari S; Saenger Y; Rousseau H; Zhao B; Schwartz LH; Dercle L
Eur Radiol; 2020 Jan; 30(1):558-570. PubMed ID: 31444598
[TBL] [Abstract][Full Text] [Related]
17. Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging.
Peng J; Kang S; Ning Z; Deng H; Shen J; Xu Y; Zhang J; Zhao W; Li X; Gong W; Huang J; Liu L
Eur Radiol; 2020 Jan; 30(1):413-424. PubMed ID: 31332558
[TBL] [Abstract][Full Text] [Related]
18. The Diagnostic Role of SPINK1 in Differentiating Hepatocellular Carcinoma From Nonmalignant Lesions.
Holah NS; El-Azab DS; Aiad HAE; Sweed DMM
Appl Immunohistochem Mol Morphol; 2017; 25(10):703-711. PubMed ID: 27028242
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular dysplastic nodules.
Roncalli M; Borzio M; Di Tommaso L
Ann Ital Chir; 2008; 79(2):81-9. PubMed ID: 18727269
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinicopathologic significance of GPC3 and other antibodies in well-differentiated hepatocellular carcinoma].
DU JL; Wei LX; Wang YL
Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):11-6. PubMed ID: 21429352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
